0001892322 false 0001892322 2023-05-22 2023-05-22 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

 

Pursuant to Section 13 or 15(d) of

the Securities Exchange Act of 1934

 

Date of report (Date of earliest event reported): May 22, 2023

 

HEARTCORE ENTERPRISES, INC.

(Exact name of registrant as specified in its charter)

 

Delaware   001-41272   87-0913420

(State or other jurisdiction

of incorporation)

 

(Commission

File Number)

 

(I.R.S. Employer

Identification Number)

 

1-2-33, Higashigotanda, Shinagawa-ku, Tokyo, Japan

(Address of principal executive offices)

 

+81-3-6409-6966

(Registrant’s telephone number, including area code)

 

N/A

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligations of the registrant under any of the following provisions.

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
   
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
   
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
   
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
Common Stock   HTCR   Nasdaq Capital Market

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company 

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. 

 

 

 

 

 

 

Item 2.02. Results of Operations and Financial Condition.

 

On May 22, 2023, HeartCore Enterprises, Inc. (the “Company”) issued a press release announcing its financial results for the three months ended March 31, 2023. A copy of this press release is attached hereto as Exhibit 99.1 and incorporated herein by reference. The information contained in any website is not a part of this Current Report on Form 8-K.

 

In accordance with General Instruction B.2 of Form 8-K, the information included in this Item 2.02, including Exhibit 99.1, shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall such information be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended (the “Securities Act”), or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.

 

Item 9.01 Financial Statement and Exhibits.

 

(d) Exhibits

 

Exhibit No.   Description
99.1   Press release of the registrant dated May 22, 2023.
104   Cover Page Interactive Data File (embedded within the Inline XBRL document)

 

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  HEARTCORE ENTERPRISES, INC.
     
Dated: May 22, 2023 By: /s/ Sumitaka Yamamoto
  Name: Sumitaka Yamamoto
  Title: Chief Executive Officer

 

 

 

Exhibit 99.1

 

 

HeartCore Reports Strong First Quarter 2023 Financial Results

 

-Company’s Q1 2023 Revenue Nearly Exceeds its Full Year 2022 Revenue

-Company’s Q1 2023 Net Income Exceeds its Full Year 2022 Net Income

 

NEW YORK, NY and TOKYO, JAPAN – May 22, 2023 – HeartCore Enterprises, Inc. (“HeartCore” or “the Company”), a leading software development company offering Customer Experience Management Platform (“CXM Platform”) and Digital Transformation (“DX”), reported financial results for the first quarter ended March 31, 2023.

 

First Quarter 2023 and Recent Operational Highlights

 

Grew total number of global enterprise customers to 916 as of March 31, 2023.
Signed tenth Go IPO consulting service agreement with rYojbaba Inc.
Integrated ChatGPT, a natural language artificial intelligence model, with HeartCore CMS to support automatic content creation for websites.
Partnered with Works Applications and AIM Consulting to improve their respective digital auditing solutions through its DX suite of offerings.
Signed eighth and ninth Go IPO clients by engaging Libera Gaming Operations and ICheck Co.
Acquired a 51% majority stake in Sigmaways Inc., a software engineering service provider delivering IT solutions.
Announced that HeartCore’s Content Management System (“CMS”) was introduced by Subaru Group to its centralized management platform for approximately 100 Subaru websites.

 

Management Commentary

 

“The first quarter was impressive in several ways, namely behind our record revenue and net income figures,” said CEO Sumitaka Yamamoto. “Our core software division drove robust operating results stemming from newly adopted marketing techniques and customer acquisition methods that were implemented last year; these changes led to profitability within this sector of our company. We are seeing this encouraging trend continue to persist which is why we are confident our software division will have a strong 2023. Additionally, our recently acquired subsidiary, Sigmaways, has been seamlessly integrated within our core operations and we’ve begun to manifest the synergies and capitalize on all joint projects.

 

“A significant contributing factor to our record-breaking quarter relates to our Go IPO business. Following the completion of two IPOs this past quarter, we’ve been able to reap the benefits from the warrants we received as part of the deal consummation. As I’ve previously shared, we have just scratched the tip of the iceberg with our Go IPO business line, as we expect to benefit from the closing of another six deals for the remainder of this year, including our biggest one yet around SBC Medical Group, which will add approximately $32.4 million to our top line. With our two-pronged growth strategy going into full effect, I am very confident in our team’s ability to make 2023 the strongest year for HeartCore across several measures.”

 

First Quarter 2023 Financial Results

 

Revenues increased 284% to $8.7 million compared to $2.3 million in the same period last year. The increase was primarily due to the expansion of the Go IPO business, as a growing number of Japanese venture companies continue to express interest in going public on the Nasdaq, in addition to the acquisition of Sigmaways and its subsidiaries.

 

Gross profit increased 361% to $5.6 million (gross margin of 64%) from $1.2 million (gross margin of 54%) in the same period last year. The increase was primarily due to the aforementioned expansion of the Company’s Go IPO business.

 

 

 

 

 

Operating expenses increased to $3.3 million from $2.8 million in the same period last year. The increase was primarily due to increased selling expenses, as well as increased general and administrative expenses.

 

Net income was $1.8 million, or $0.10 per diluted share, compared to net loss of approximately $1.6 million or $(0.09) per diluted share last year. The increase in net income was primarily due to the aforementioned expansion of the Company’s Go IPO business in addition to relatively stable operating expenses.

 

As of March 31, 2023, the Company had cash and cash equivalents of $5.2 million compared to $7.2 million as of December 31, 2022.

 

About HeartCore Enterprises, Inc.

 

Headquartered in Tokyo, Japan, HeartCore Enterprises is a leading software development company offering Software as a Service (SaaS) solutions to enterprise customers in Japan and worldwide. The Company also provides data analytics services that allow enterprise businesses to create tailored web experiences for their clients through best-in-class design. HeartCore’s customer experience management platform (CXM Platform) includes marketing, sales, service and content management systems, as well as other tools and integrations, which enable companies to enhance the customer experience and drive engagement. HeartCore also operates a digital transformation business that provides customers with robotics process automation, process mining and task mining to accelerate the digital transformation of enterprises. Furthermore, HeartCore offers “Go IPO,” a consulting service where it assists private companies with uplisting onto the Nasdaq Stock Market. Additional information about the Company’s products and services is available at www.heartcore.co.jp and https://heartcore-enterprises.com/.

 

Forward-Looking Statements

 

All statements other than statements of historical facts included in this press release are forward- looking statements. In some cases, forward-looking statements can be identified by words such as “believe,” “intend,” “expect,” “anticipate,” “plan,” “potential,” “continue” or similar expressions. Such forward-looking statements include risks and uncertainties, and there are important factors that could cause actual results to differ materially from those expressed or implied by such forward-looking statements. These factors, risks, and uncertainties are discussed in HeartCore’s filings with the Securities and Exchange Commission. Investors should not place any undue reliance on forward-looking statements since they involve known and unknown, uncertainties and other factors which are, in some cases, beyond HeartCore’s control which could, and likely will materially affect actual results, and levels of activity, performance, or achievements. Any forward-looking statement reflects HeartCore’s current views with respect to future events and is subject to these and other risks, uncertainties, and assumptions relating to operations, results of operations, growth strategy, and liquidity. HeartCore assumes no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future. The contents of any website referenced in this press release are not incorporated by reference herein.

 

HeartCore Investor Relations Contact:

 

Gateway Group, Inc.

Matt Glover and John Yi

HTCR@gatewayir.com

(949) 574-3860

 

 

 

 

 

HeartCore Enterprises, Inc.

Unaudited Condensed Consolidated Statements of Operations and Comprehensive Income (Loss)

 

   

For the Three Months Ended

March 31,

 
    2023     2022  
Revenues   $ 8,734,150     $ 2,276,001  
                 
Cost of revenues     3,101,066       1,055,356  
                 
Gross profit     5,633,084       1,220,645  
                 
Operating expenses:                
Selling expenses     568,642       205,918  
General and administrative expenses     2,685,207       2,468,933  
Research and development expenses     79,624       108,259  
                 
Total operating expenses     3,333,473       2,783,110  
                 
Income (loss) from operations     2,299,611       (1,562,465 )
                 
Other income (expenses):                
Changes in fair value of investments in warrants     193,365       -  
Interest income     31,605       1,458  
Interest expenses     (39,840 )     (11,271 )
Other income     14,201       16,673  
Other expenses     (29,457 )     (23,662 )
Total other income (expenses)     169,874       (16,802 )
                 
Income (loss) before income tax provision     2,469,485       (1,579,267 )
                 
Income tax expense (benefit)     661,448       (816 )
                 
Net income (loss)     1,808,037       (1,578,451 )
                 
Less: net loss attributable to non-controlling interest     (74,252 )     -  
                 
Net income (loss) attributable to HeartCore Enterprises, Inc.   $ 1,882,289     $ (1,578,451 )
                 
Other comprehensive income (loss):                
Foreign currency translation adjustment     (25,034 )     80,053  
                 
Total comprehensive income (loss)     1,783,003       (1,498,398 )
Less: comprehensive loss attributable to non-controlling interest     (76,542 )     -  
Comprehensive income (loss) attributable to HeartCore Enterprises, Inc.   $ 1,859,545     $ (1,498,398 )
                 
Net income (loss) per common share attributable to HeartCore Enterprises, Inc.                
Basic   $ 0.10     $ (0.09 )
Diluted   $ 0.10     $ (0.09 )
Weighted average common shares outstanding                
Basic     19,066,160       17,265,332  
Diluted     19,066,160       17,265,332  

 

 

 

 

 

HeartCore Enterprises, Inc.

Condensed Consolidated Balance Sheets

 

   March 31, 2023   December 31, 2022 
   (Unaudited)     
ASSETS          
           
Current assets:          
Cash and cash equivalents  $5,209,915   $7,177,326 
Accounts receivable   2,380,128    551,064 
Short-term investment in warrants   437,812    - 
Prepaid expenses   919,916    538,230 
Due from related party   47,536    48,447 
Other current assets   31,534    220,070 
Total current assets   9,026,841    8,535,137 
           
Non-current assets:          
Property and equipment, net   214,566    203,627 
Operating lease right-of-use assets   2,549,834    2,644,957 
Intangible asset, net   4,993,750    - 
Goodwill   3,276,441    - 
Long-term investment in warrants   3,764,888    - 
Deferred tax assets   245,997    263,339 
Security deposits   367,981    244,395 
Long-term loan receivable from related party   229,955    246,472 
Other non-current assets   75    661 
Total non-current assets   15,643,487    3,603,451 
           
Total assets  $24,670,328   $12,138,588 
           
LIABILITIES AND SHAREHOLDERS’ EQUITY          
           
Current liabilities:          
Accounts payable and accrued expenses  $1,160,309   $497,742 
Accrued payroll and other employee costs   416,779    360,222 
Due to related party   2,923    402 
Current portion of long-term debts   640,534    697,877 
Insurance premium financing   352,518    - 
Factoring liability   173,582    - 
Operating lease liabilities, current   288,081    291,863 
Finance lease liabilities, current   13,663    19,294 
Income tax payables   681,830    2,747 
Deferred revenue   1,530,472    1,724,519 
Other current liabilities   225,167    53,027 
Total current liabilities   5,485,858    3,647,693 
           
Non-current liabilities:          
Long term debts   1,490,664    1,123,735 
Operating lease liabilities, non-current   2,314,160    2,421,054 
Finance lease liabilities, non-current   -    459 
Deferred tax liabilities   1,398,250    - 
Other non-current liabilities   135,536    138,018 
Total non-current liabilities   5,338,610    3,683,266 
           
Total liabilities   10,824,468    7,330,959 
           
Shareholders’ equity:          
Preferred shares ($0.0001 par value, 20,000,000 shares authorized, no shares issued and outstanding as of March 31, 2023 and December 31, 2022, respectively)   -    - 
Common shares ($0.0001 par value, 200,000,000 shares authorized; 20,842,690 and 17,649,886 shares issued and outstanding as of March 31, 2023 and December 31, 2022, respectively)   2,083    1,764 
Additional paid-in capital   19,079,516    15,014,607 
Accumulated deficit   (8,691,290)   (10,573,579)
Accumulated other comprehensive income   342,093    364,837 
Total HeartCore Enterprises, Inc. shareholders’ equity   10,732,402    4,807,629 
Non-controlling interest   3,113,458    - 
Total shareholders’ equity   13,845,860    4,807,629 
           
Total liabilities and shareholders’ equity  $24,670,328   $12,138,588 

 

 

 

 

HeartCore Enterprises, Inc.

Unaudited Condensed Consolidated Statements of Cash Flows

 

   For the
three months ended
   For the
three months ended
 
   March 31, 2023   March 31, 2022 
         
Cash flows from operating activities          
Net income (loss)  $1,808,037   $(1,578,451)
Adjustments to reconcile net income (loss) to net cash used in operating activities:          
Depreciation and amortization expenses   123,312    24,889 
Amortization of debt issuance costs   758    866 
Non-cash lease expense   76,017    75,986 
Deferred income taxes   (17,284)   6,311 
Stock-based compensation   915,228    422,164 
Changes in fair value of investments in warrants   (193,365)   - 
Changes in assets and liabilities:          
Accounts receivable   (66,833)   (217,638)
Investments in warrants   (4,009,335)   - 
Prepaid expenses   (45)   (488,970)
Other assets   78,241    (34,896)
Accounts payable and accrued expenses   (94,363)   (79,982)
Accrued payroll and other employee costs   (178,733)   (27,492)
Due to related party   2,544    - 
Operating lease liabilities   (73,147)   (78,226)
Finance lease liabilities   (53)   (174)
Income tax payables   678,725    (10,037)
Deferred revenue   (167,873)   (295,176)
Other liabilities   70,110    (113,027)
Net cash flows used in operating activities   (1,048,059)   (2,393,853)
           
Cash flows from investing activities          
Purchases of property and equipment   (9,409)   (18,903)
Advance and loan provided to related party   -    (25,480)
Repayment of loan provided to related party   11,955    9,102 
Payment for acquisition of subsidiary, net of cash acquired   (724,910)   - 
Net cash flows used in investing activities   (722,364)   (35,281)
           
Cash flows from financing activities          
Proceeds from initial public offering, net of issuance cost   -    13,602,554 
Proceeds from issuance of common shares prior to initial public offering   -    220,572 
Payments for finance leases   (5,658)   (14,916)
Proceeds from long-term debt   -    258,087 
Repayment of long-term debts   (265,255)   (308,121)
Repayment of insurance premium financing   (36,517)   (41,280)
Repayment to related party   -    (903)
Net proceeds from factoring arrangement   173,582    - 
Payments for debt issuance costs   (448)   (1,030)
Payment for mandatorily redeemable financial interest   -    (430,489)
Net cash flows provided by (used in) financing activities   (134,296)   13,284,474 
           
Effect of exchange rate changes   (62,692)   (78,293)
           
Net change in cash and cash equivalents   (1,967,411)   10,777,047 
           
Cash and cash equivalents - beginning of the period   7,177,326    3,136,839 
           
Cash and cash equivalents - end of the period  $5,209,915   $13,913,886 
           
Supplemental cash flow disclosures:          
Interest paid  $16,968   $13,262 
Income taxes paid  $-   $1,489 
           
Non-cash investing and financing transactions          
Payroll withheld as repayment of loan receivable from employees  $-   $2,065 
Expense paid by related party on behalf of the Company  $-   $25,480 
Share repurchase liability settled by issuance of common shares  $-   $16 
Deferred offering costs recognized against the proceeds from the offering  $-   $178,847 
Insurance premium financing  $389,035   $388,538 
Liabilities assumed in connection with purchase of property and equipment  $6,288   $- 
Common shares issued for acquisition of subsidiary  $3,150,000   $-